Founders & Board Members
Jamie Zhan, DPhil, MPH
Abraham (Nick) Morse, MD, MBA
Jamie Zhan, DPhil, MPH
Founder & President
Decade-long experience in global biopharma management, business development & fundraise
University of Oxford, PhD
Harvard University, MPH
Christopher Hine, PhD
Abraham (Nick) Morse, MD, MBA
Jamie Zhan, DPhil, MPH
Scientific Co-Founder
Assoc. Prof. Cleveland Clinic
Global scientific leader in ageing biology, numerous top journal publications, ~7000 citations
Abraham (Nick) Morse, MD, MBA
Abraham (Nick) Morse, MD, MBA
Abraham (Nick) Morse, MD, MBA
Board & Medical Director
Adj. Prof. Tufts School of Medicine
30+ years Experience in Clinical Medicine & Healthcare Industry (OB/GYN, Pelvic Surgery)
Scientific Advisors & Executives
David Keefe, MD
Christopher Hine, PhD
Christopher Hine, PhD
Scientific Advisor
Chief, Reproductive Medicine,
UMass Chan School of Medicine
30+ years in clinical medicine, 200+ publications & patents in fertility medicine
Christopher Hine, PhD
Christopher Hine, PhD
Christopher Hine, PhD
Head of Chemistry
30+ years in drug development;
ex VP Bristol-Myers-Squibb, founding consultants incl. Black Diamond Therapeutics
Robert Clay, MBA
Christopher Hine, PhD
Robert Clay, MBA
Head of Regulatory Affairs
30+ years in regulatory affairs with a track record of success in global programs; ex-Executive Director, Pfizer, VP AstraZeneca
Jay Patel, MS, TS (ABB)
Jay Patel, MS, TS (ABB)
Jay Patel, MS, TS (ABB)
Scientific Advisor
IVF Laboratory Technical Director, Brigham and Women’s Hospital
30 years in embryology, IVF techniques, & clinical lab management
Hanno Steen, PhD
Jay Patel, MS, TS (ABB)
Jay Patel, MS, TS (ABB)
Scientific Advisor
Professor, Harvard Medical School/ Boston Children's Hospital
Pioneer in high-throughput proteomics; 10+ patents in proteomics technology
Kevin Munnelly, MBA
Jay Patel, MS, TS (ABB)
Kevin Munnelly, MBA
Strategy Advisor
SVP, Third Rock Ventures
30+ years in therapeutic technology platforms, spanning synthetic biology, small molecule and biologies, and diagnostic technologies
Arthur de Garidel, JD, MPH
Kevin Calloway, MBA Candidate ('26)
Arthur de Garidel, JD, MPH
Head of Business Development
10 years in BD & Licensing, successful deals with global pharma, incl. Korro’s >$500M deal with Novo Nordisk; ex-Bain, Accenture
Jayati Aggarwal, PhD
Kevin Calloway, MBA Candidate ('26)
Arthur de Garidel, JD, MPH
Head of Biology
Executive Director, FluidAI
10 years in Large language model for business applications
University of Oxford, PhD
Kevin Calloway, MBA Candidate ('26)
Kevin Calloway, MBA Candidate ('26)
Kevin Calloway, MBA Candidate ('26)
Head of Operations
Enabled $1B+ revenue increase through manuf. innovation & digital transformation, Operations & Supply Chain Lead, Pfizer